30 Day Trial
ORTHOKNOW logo

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Quarterly Review

4Q13/2013 Revenue: ArthroCare

4Q13 orthopaedic revenue: $69.6MM, +5% (U.S. $44.1MM, +6%; ex-U.S. $25.4MM, +5%)

  • Sports Medicine $67.4MM, +6% (U.S. $43.8MM, +6%; ex-U.S. $23.5MM, +6%)
  • Other (includes Spine) $2.2MM, -14% (U.S. $0.3MM, -39%; ex-U.S. $1.8MM, -8%)

 

2013 orthopaedic revenue: $252.7MM, +3% (U.S. $159.5MM, +2%; ex-U.S. $93.1MM, +6%)

  • Sports Medicine $244MM, +4% (U.S. $158.0MM, +2%; ex-U.S. $85.9MM, +6%)
  • Other (includes Spine) $8.7MM, -5% (U.S. $1.4MM, -18%; ex-U.S. $7.1MM, -2%)

 

ArthroCare did not convene an earnings call.